# Cytogen, Inc. (217330.KQ): MoatMap facts

As of 20 Oct 2026. Research data, not investment advice.

As of 20 Oct 2026, MoatMap's StockRank for Cytogen, Inc. (217330.KQ) is 9/100, ranked against 24,000+ stocks in 35 markets (Quality 31, Value 33, Momentum 17, each scored against its sector).

- StockRank: 9/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 31, Value 33, Momentum 17: each a 0-100 percentile within the stock's sector.
- Position: #24,470 overall, #2,332 in Healthcare.
- Listing: South Korea, KOE; Healthcare / Diagnostics & Research.
- Last close: 2,700 KRW on 19 Oct 2026.
- Insider filings, last 180 days: directors sold USD 1.6M; 5%+ holders sold USD 1.6M.

Source: https://moatmap.ai/stock/217330.KQ
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker